Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04115254
NA

Stereotactic Magnetic Resonance Guided Radiation Therapy

Sponsor: Dana-Farber Cancer Institute

View on ClinicalTrials.gov

Summary

This is a master prospective Phase I-II trial evaluating feasibility and efficacy of stereotactic magnetic resonance (MR) guided adaptive radiation therapy (SMART) in patients with cancer. * The phase 1 study will evaluate the feasibility and safety of delivering SMART in patients with cancer. * Phase 2 will evaluate efficacy of SMART with specific reference to tumor control and improvement in patient reported outcome measures

Official title: A Master Protocol of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy (SMART)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

397

Start Date

2019-10-22

Completion Date

2028-06

Last Updated

2025-11-13

Healthy Volunteers

No

Interventions

RADIATION

MR-guided Linac

Radiation will be delivered on an MR-guided Linear Accelerator

Locations (2)

Brigham & Women's Hospital

Boston, Massachusetts, United States

Dana Farber Cancer Institute

Boston, Massachusetts, United States